Multicriteria decision analysis for HER2-positive non-metastatic breast cancer
Journal of Oncology Pharmacy Practice
Published online on January 29, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionMulticriteria Decision Analysis (MCDA) comprises a set of methods that support decision making in Health Technology Assessment (HTA). MCDA studies that support the incorporation of new treatments for non-metastatic HER2-positive breast cancer ...
IntroductionMulticriteria Decision Analysis (MCDA) comprises a set of methods that support decision making in Health Technology Assessment (HTA). MCDA studies that support the incorporation of new treatments for non-metastatic HER2-positive breast cancer ...